Where to Advertise Mass Torts in 2026: Costs, Benchmarks and Strategy

Most Firms Are Spending on the Wrong Mass Tort Advertising Channels

Mass tort advertising channels span six distinct media categories, television, paid search, social media, programmatic display, legal aggregators, and co-counsel referral networks, each carrying different cost structures, claimant volume ceilings, and signed-retainer economics. For plaintiff firms building a docket in 2026, channel selection is no longer a media preference; it is a case-economics decision that determines whether a litigation investment pencils out before discovery begins. This post delivers current cost benchmarks, realistic conversion data, and a strategic framework for allocating budget across channels.

Why Channel Selection Defines Case Economics

Mass tort intake is a volume and margin game. A firm that signs 200 cases at $800 cost per signed case is in a fundamentally different position than a firm that signs 200 cases at $2,400. Over a docket of any meaningful size, that spread determines whether a tort is profitable before a settlement ever comes, or whether you are carrying financial exposure you did not price for.

Channel selection drives that spread more than almost any other variable. The creative matters, the intake process matters, the retainer conversion rate matters. But if you are running the right message on the wrong channel, or buying in a market where your cost per qualified lead is structurally too high for the case values projected in that tort, you are losing before the campaign even gets optimized.

Every mass tort has a window. MDL posture, settlement timing, and competitive inventory pressure all shift that window. The channels you use, and how aggressively you fund them, need to match where the tort actually sits in its lifecycle.

The Major Mass Tort Advertising Channels: A Firm-Level Breakdown

Facebook and Meta

Meta remains the highest-volume, most scalable paid channel for mass tort claimant acquisition. The targeting depth, the creative flexibility, and the sheer size of the reachable audience make it the default primary channel for most torts. Over $250 million in managed Facebook spend across 600-plus plaintiff firms and 100-plus torts has taught me one consistent lesson: Meta rewards firms that invest in creative testing early and punishes firms that run one ad set and wait.

Realistic CPL (cost per lead) on Facebook for a mid-tier mass tort runs $40 to $120 depending on the tort, the geographic market, and how competitive the landscape is at the moment you enter. Cost per signed case typically lands between $600 and $1,800 for well-run campaigns. When you see CPSCs above $2,500, you are usually looking at weak intake conversion, not bad leads.

The compliance ceiling on Meta is real. The platform has restrictions on health-related targeting, and ad copy that reads as medical advice or uses before-and-after framing around drug side effects will get disapproved or restricted. Strong creative teams know how to frame campaigns within policy without gutting conversion.

Television, Including OTT and Streaming

Linear TV built the mass tort industry, and it still works for certain firm profiles. National cable buys for large, high-recognition torts (think Roundup, NEC baby formula, AFFF) can drive high call volume quickly. The problem is efficiency. TV CPLs are harder to control, attribution is messier, and the minimum spend thresholds to move the needle are higher than digital.

OTT and connected TV (CTV) have changed this calculus. Programmatic streaming buys let firms reach specific demographic and behavioral audiences with video inventory, with better attribution than linear. For firms that want video reach without committing to a full broadcast budget, OTT has become a meaningful secondary channel, particularly for torts where the claimant pool skews older and television consumption is higher.

Google Search and YouTube

Paid search captures demand that already exists. When someone searches "Ozempic lawsuit" or "Camp Lejeune attorney," they have already connected their situation to potential legal action. That intent makes search leads convert at higher rates, which is why search CPLs are often two to three times higher than social.

For torts with strong organic search volume, Google can be a cost-effective complement to Facebook. For torts in earlier stages where public awareness is lower, you are essentially paying to intercept a small audience and the economics rarely pencil out as a primary channel. YouTube pre-roll and in-stream ads occupy a middle position: video creative with some intent signal from the user's viewing context, lower CPLs than search, better brand recall than static social.

Co-Registration and Lead Aggregators

Third-party lead networks and co-registration sources offer volume at an apparent discount. The leads are bought, often shared, and frequently aged before they reach your intake team. Shared leads in competitive torts convert at a fraction of the rate of exclusive, self-generated leads. The math on paper looks attractive. The math after 90 days of intake data usually does not.

Some aggregators run legitimate, exclusive lead programs for specific torts. Vetting them requires full transparency on lead sourcing, exclusivity guarantees in writing, and enough volume to build a statistically meaningful sample before committing to scale. Firms that skip that diligence consistently overpay on a cost-per-signed-case basis.

Organic Search and Content

SEO is a long game that most mass torts cannot afford to wait for, but it is worth mentioning because firms with strong domain authority and content infrastructure can generate low-cost leads for torts where the lifecycle is long enough. For the average plaintiff firm evaluating where to put capital in the next 90 days, SEO is a supplement, not a strategy.

The Numbers: What "Good" Actually Looks Like

Good benchmarks shift by tort and by timing, but here is a working framework for evaluating channel performance.

• Facebook CPL: $40 to $120 for most active torts. Above $150 warrants creative review or audience reassessment.
• Facebook cost per signed case: $600 to $1,800. Above $2,000 means intake is bleeding leads, not that the channel is broken.
• Google Search CPL: $150 to $400 for high-intent torts. Conversion rates from lead to sign are higher, so the CPSC can still compete.
• OTT/CTV CPL: Harder to isolate, but firms using it as a brand lift layer on top of paid social typically see 8 to 15 percent improvement in Facebook conversion rates in overlapping markets.
• Shared leads from aggregators: Expect 20 to 40 percent of the conversion rate of self-generated exclusive leads. Price accordingly.

The metric that actually matters is cost per signed case, not cost per lead. Any firm optimizing to CPL without tracking conversion through intake to signed retainer is flying partially blind.

How to Execute Well: What Separates Winners from Money-Losers

Channel mix matters, but execution within each channel is what moves the economics. A few principles that consistently separate high-performing firms from the rest.

First, creative testing is not optional. On Facebook especially, the ad itself determines whether the algorithm can find your audience. Firms that run one creative and scale spend on it without testing alternatives are leaving performance on the table. Budget two to three weeks and 15 to 20 percent of initial spend for structured creative testing before scaling.

Second, your intake speed directly affects your channel ROI. A lead that waits four hours for a call is worth a fraction of a lead contacted in under ten minutes. Speed-to-contact is the single highest-leverage variable after the ad itself. AI-powered intake tools, including automated SMS follow-up and voice AI for initial qualification, have become real options for plaintiff firms in the last 18 months and are worth serious evaluation. For a practical look at where AI fits inside a law firm's operations, my book "A Lawyer's Guide to AI" covers this from a plaintiff bar perspective.

Third, match your channel investment to the tort's lifecycle. Early-stage torts with emerging awareness are Facebook-first. Later-stage torts near settlement with high public awareness support broader multi-channel approaches including OTT and search.

Pitfalls and Compliance Issues That Trip Firms Up

The bar rules on attorney advertising vary by state and the multi-state nature of mass tort campaigns creates real compliance exposure. Disclaimer requirements, prior approval rules in certain jurisdictions, and restrictions on specific claims about outcomes are all live issues. Running national campaigns without a compliance review process is a risk most firms underestimate.

TCPA and CIPA exposure on the intake side is significant. Texting claimants who did not opt in, using automated dialing systems without proper consent, recording intake calls without required disclosures, these are not hypothetical risks. Demand letter mills actively monitor mass tort advertisers. Building consent architecture into your lead forms and intake workflows is not optional.

On the spend side, the most common waste pattern is spreading budget thin across too many channels before any single channel is optimized. Firms that try to run Facebook, Google, OTT, and radio simultaneously with modest budgets usually generate mediocre results everywhere. Concentrate spend to get a real signal, optimize, then expand.

How MTAA Approaches This for Plaintiff Firms

At Mass Tort Ad Agency, we run full-service campaigns across the major mass tort advertising channels with a transparent cost-plus model: you see exactly what goes to ad spend, and our fee is 15 percent on top. No hidden markups, no opaque media buys. That structure matters because it aligns our incentives with your cost per signed case, not with inflating gross spend.

Across $250 million-plus in managed spend and more than 600 plaintiff firms, the pattern is consistent: firms that win in mass tort advertising treat channel selection and creative testing as ongoing strategic decisions, not one-time setup tasks. The ones that struggle tend to set campaigns and expect them to run on autopilot.

We work across 100-plus torts at any given time, which means our benchmarks are current and cross-referenced against real market conditions, not historical averages from two cycles ago.

Choosing the Right Mass Tort Advertising Channels for Your Firm

There is no universal answer to where a firm should advertise. The right mix of mass tort advertising channels depends on the tort's stage, the claimant pool size, the projected case value, your intake infrastructure, and the competitive dynamics in your target markets. What is consistent is that firms which approach channel selection with discipline, track the right metrics, and invest in execution rather than just budget, build dockets that perform. The firms that buy on gut or chase the cheapest CPL without understanding what happens after the lead arrives usually find out the hard way why mass tort advertising channels require the same analytical rigor as any other major capital allocation decision inside a plaintiff practice.